MURR

Sep. 5, 2024

University of Missouri Research Reactor (MURR) wins Hawthorn Foundation Project of the Year Award

Recognition underscores MURR’s pivotal role in positioning Missouri as a leader in nuclear science and technology.

Aug. 20, 2024

MU Research Reactor partners with Institute of Nuclear Power Operations

This new collaboration will further enhance MURR’s operational standards, ensuring the highest levels of safety and efficiency.

July 24, 2024

Pioneering progress in cancer treatments

From its research reactor to revolutionary therapies, Mizzou’s innovations are shaping the future of precision medicine.

July 17, 2024

University of Missouri Research Reactor joins Nuclear Medicine Europe

July 12, 2024

Innovations and information

IT leaders from across the SEC gathered at Mizzou for their annual meeting.

June 4, 2024

Michael Hoehn II named inaugural program director of NextGen MURR

Hoehn will lead Mizzou’s transformational initiative to build a new state-of-the-art research reactor that will expand medical isotope production.

March 28, 2024

Innovative yttrium-90 radioisotopes revolutionize liver cancer treatment

Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor are extending and improving the lives of patients with liver cancer.

Jan. 30, 2024

Sparking innovation for research

A scanning electron microscope at the University of Missouri Research Reactor will enhance the facility’s investigative capabilities for materials research and discoveries.

Dec. 13, 2023

MU Health Care pilots breakthrough treatment for prostate cancer

Treatment uses radioisotopes produced in the University of Missouri Research Reactor.

Dec. 6, 2023

MU Research Reactor announces commercial shipments of breakthrough radioisotope for cancer treatment

The University of Missouri Research Reactor (MURR) is the only U.S. supplier of the radioisotope, produced using a propriety process developed at MURR.